Biopharma/Biotech Analyst Chen & Biotech Analyst Agrawal, along with Drs. Pajvani & Acholonu discuss obesity and related metabolic diseases post American Diabetes Association’s sessions (relevant companies NVO, LLY, PFE, AMGN, VKTX, RYTM) on an Analyst/Industry conference call to be held on June 28 at 1 pm. Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on NVO:
- Eli Lilly (NYSE:LLY) Touts Superior Results of Weight Loss Shot
- Pfizer’s (NYSE:PFE) Oral Obesity Drug Plans Get Leaner
- Drug makers are developing pill version of weight-loss drugs, WSJ reports
- EMA raises safety signal on Novo Nordisk drugs including Ozempic, Reuters says
- Novo Nordisk Takes Legal Route to Crack Down on Copycat Drugs